Azenta (NASDAQ:AZTA – Get Free Report) is projected to release its Q4 2026 results after the market closes on Tuesday, November 10th. Analysts expect the company to announce earnings of $0.1110 per share and revenue of $160.21 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2026 earnings report for the latest details on the call scheduled for Wednesday, November 11, 2026 at 8:30 AM ET.
Azenta (NASDAQ:AZTA – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. The firm had revenue of $161.18 million during the quarter, compared to analysts’ expectations of $149.31 million. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%.
Azenta Trading Up 4.5%
Shares of Azenta stock traded up $1.61 during trading on Tuesday, hitting $37.16. 343,556 shares of the stock were exchanged, compared to its average volume of 937,958. The company has a fifty day moving average price of $34.93 and a 200-day moving average price of $28.50. The stock has a market capitalization of $1.63 billion, a price-to-earnings ratio of -13.44 and a beta of 1.52. Azenta has a 1-year low of $15.93 and a 1-year high of $46.41.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on AZTA shares. Weiss Ratings upgraded Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 26th. Needham & Company LLC restated a “buy” rating and issued a $37.00 price objective on shares of Azenta in a research note on Monday, September 14th. Finally, Wall Street Zen cut Azenta from a “buy” rating to a “hold” rating in a research report on Sunday, October 18th. Four investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $41.20.
Get Our Latest Stock Analysis on Azenta
Azenta Company Profile
Azenta, Inc is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical, biotechnology, academic, and clinical research organizations throughout the sample lifecycle, from collection and processing to long-term storage and retrieval.
The company’s portfolio includes automated and ultra-low-temperature sample storage systems, laboratory automation equipment, consumables, and software for sample tracking and management.
Featured Stories
- Five stocks we like better than Azenta
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
- Republic Services Has the Momentum, But Waste Management Has Another Advantage
- Alphabet’s Golden Dome Talks Could Open a New Market, But How Much Is at Stake?
- Tempus AI Surges on Earnings Beat, But Can the Rally Last?
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.
